SPIRE HEALTHCARE GROUP PLC financials
SPIRE HEALTHCARE GROUP PLC
213800IBJPW3SE2RA350 ISIN: GB00BNLPYF73 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | £1.58B | £1.51B |
| Cost of sales | £863.7M | £827.6M |
| Gross profit | £716.1M | £683.6M |
| Other income | £3.4M | £12.6M |
| Operating profit (EBIT) | £122.6M | £137.5M |
| Finance costs | £105.0M | £99.9M |
| Profit before tax | £18.6M | £38.3M |
| Income tax expense | £1.4M | £12.3M |
| Profit for the year | £17.2M | £26.0M |
| — attributable to owners | £16.4M | £25.4M |
| — attributable to NCI | £800.0K | £600.0K |
| Total comprehensive income | £15.2M | £24.8M |
| Per share | ||
| Basic EPS | £0.04 | £0.06 |
| Diluted EPS | £0.04 | £0.06 |
| Free cash flow / share | £0.39 | £0.30 |
| Cash flow statement | ||
| Cash generated from operations | £242.4M | £235.8M |
| Net cash from operating activities | £242.2M | £235.7M |
| Income taxes paid | £200.0K | £100.0K |
| Net cash from investing activities | -£84.2M | -£99.0M |
| Purchase of PP&E (capex) | £76.3M | £109.3M |
| Purchase of intangibles | £2.2M | £2.8M |
| Net cash from financing activities | -£164.5M | -£145.1M |
| Dividends paid | £9.2M | £8.5M |
| Lease liability payments | £35.1M | £26.2M |
| Balance sheet | ||
| Total assets | £2.38B | £2.34B |
| Non-current assets | £2.16B | £2.12B |
| Property, plant & equipment | £1.69B | £1.66B |
| Intangible assets & goodwill | £444.8M | £437.4M |
| Current assets | £221.5M | £225.3M |
| Inventories | £46.2M | £46.6M |
| Trade & other receivables | £136.5M | £131.4M |
| Cash & equivalents | £34.7M | £41.2M |
| Total equity | £743.7M | £746.2M |
| — attributable to owners | £742.8M | £748.4M |
| Non-controlling interests | £900.0K | -£2.2M |
| Non-current liabilities | £1.29B | £1.26B |
| Long-term borrowings | £364.0M | £363.5M |
| Lease liabilities (non-current) | £841.1M | £811.0M |
| Current liabilities | £346.8M | £341.7M |
| Short-term borrowings | £3.1M | £3.6M |
| Lease liabilities (current) | £107.6M | £101.8M |
| Trade & other payables | £218.1M | £214.0M |
| Deferred tax liabilities | £81.3M | £80.8M |
| Derived metrics | ||
| Free cash flow | £165.9M | £126.4M |
| Operating margin | 7.8% | 9.1% |
| Net margin | 1.1% | 1.7% |
| Return on equity | 2.3% | 3.5% |
| Cash conversion ratio | 14.08× | 9.07× |
| Capex coverage | 3.17× | 2.16× |
| Other reported items | ||
| Cancellation of Treasury Shares | — | -£3.1M |
| Capital Redemption Reserve | £0 | £0 |
| Capital Reserve | £376.1M | £376.1M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | £7.7M | £0 |
| Comprehensive Income Attributable To Noncontrolling Interests | £800.0K | £600.0K |
| Comprehensive Income Attributable To Owners of Parent | £14.4M | £24.2M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | £217.6M | £224.2M |
| Current Derivative Financial Assets | £200.0K | £2.5M |
| Current Financial Assets | £0 | £2.5M |
| Current Financial Liabilities | £1.6M | £8.0M |
| Current Provisions | £16.3M | £14.2M |
| Current Tax Liabilities Current | £100.0K | £100.0K |
| Decrease Increase Through Tax On Sharebased Payment Transactions | £100.0K | -£400.0K |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | £9.2M | £8.5M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | £500.0K | £700.0K |
| Dividends Recognised As Distributions To Noncontrolling Interests | £500.0K | £700.0K |
| Equity and Liabilities | £2.38B | £2.34B |
| Finance Income | £1.0M | £700.0K |
| Gains Losses On Cash Flow Hedges Before Tax | -£2.9M | -£1.5M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | -£900.0K | -£300.0K |
| Increase Decrease In Cash and Cash Equivalents | -£6.5M | -£8.4M |
| Increase Decrease Through Sharebased Payment Transactions | £1.6M | £4.0M |
| Interest Received Classified As Investing Activities | £400.0K | £700.0K |
| Issued Capital | £4.0M | £4.0M |
| Liabilities | £1.63B | £1.60B |
| Miscellaneous Other Operating Expense | £596.9M | £558.7M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | £3.9M | £1.1M |
| Noncurrent Derivative Financial Assets | £0 | £400.0K |
| Noncurrent Derivative Financial Liabilities | £200.0K | £0 |
| Noncurrent Financial Assets | £14.4M | £12.3M |
| Other Comprehensive Income | -£2.0M | -£1.2M |
| Other Noncurrent Receivables | £4.3M | £4.4M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | £0 | £11.7M |
| Reserve of Cash Flow Hedges | £100.0K | £2.1M |
| Retained Earnings | -£463.2M | -£462.9M |
| Share Premium | £830.0M | £830.0M |
Every line item above is a fact tagged in SPIRE HEALTHCARE GROUP PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.